Adverts

Open Access Articles- Top Results for Vilanterol

Vilanterol

</th></tr>
Vilanterol
File:Vilanterol.svg
Systematic (IUPAC) name
4-{(1R)-2-[(6-{2-[(2,6-Dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
Clinical data
Identifiers
R03AK10 (+fluticasone)
R03AL03 (+umeclidinium)
PubChem CID 10184665
ChemSpider 8360167
ChEBI CHEBI:75037
Chemical data
Formula C24H33Cl2NO5
486.43 g/mol

Vilanterol (USAN) is a long-acting beta-2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1] Vilanterol is available on combinations, for example with fluticasone Furoate (Breo in the US; Relvar Ellipta in the UK) or with umeclidinium (Anoro in Europe).

References


Lua error in package.lua at line 80: module 'Module:Buffer' not found.